425: CoreWeave Details Proposed Acquisition of Core Scientific, Highlights Transaction Risks and SEC Filing Requirements

CoreWeave, Inc. has announced its proposed acquisition of Core Scientific, Inc., outlining the necessary SEC filings and potential risks associated with the transaction.

Summary

• CoreWeave, Inc. is proposing to acquire Core Scientific, Inc.
• Both CoreWeave and Core Scientific will file relevant materials with the U.S. Securities and Exchange Commission (SEC), including a registration statement on Form S-4 by CoreWeave, which will incorporate a proxy statement of Core Scientific and a prospectus of CoreWeave.
• A definitive proxy statement/prospectus will be mailed to Core Scientific stockholders.
• The communication serves as an informational notice and is not an offer to sell or a solicitation of an offer to buy securities, nor a solicitation of any vote or approval.
• Investors and security holders are urged to read the registration statement, proxy statement/prospectus, and other relevant documents filed with the SEC carefully and in their entirety when they become available.
• Information regarding participants in the proxy solicitation, including directors and executive officers of both companies, is available in their respective prior SEC filings.
• The communication contains forward-looking statements regarding the consummation and anticipated benefits of the proposed transaction, which are subject to various risks and uncertainties.

Sentiment

Score: 4

Explanation: The document is a standard legal disclosure for a proposed acquisition, heavily emphasizing risks and disclaimers rather than positive outcomes or financial performance. While the underlying transaction aims for synergies, the communication itself is cautious and procedural.

Positives

• The proposed transaction aims to achieve anticipated synergies and value creation between CoreWeave and Core Scientific.
• The transaction is intended to allow CoreWeave and Core Scientific to successfully integrate their businesses.

Negatives

• The proposed transaction may not be completed on anticipated terms, or at all, including potential delays in obtaining regulatory and Core Scientific stockholder approvals.
• Anticipated benefits of the proposed transaction may not be realized or may not be realized within the expected time period.
• The transaction could be more expensive to complete than anticipated due to unexpected factors or events.
• Disruptions from the proposed transaction could harm CoreWeave's or Core Scientific's business, including current plans and operations.
• Management's time and attention may be diverted to transaction-related issues.
• Potential adverse reactions or changes to business relationships could result from the announcement or completion of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions.

Risks

• Completion of the proposed transaction on anticipated terms, or at all, and timing of completion, including obtaining required regulatory approvals and Core Scientific stockholder approval.
• Anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the combined company.
• The possibility that any of the anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• The ability of CoreWeave and Core Scientific to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.
• The risk that disruptions from the proposed transaction will harm CoreWeave's or Core Scientific's business, including current plans and operations, and that management's time and attention will be diverted on transaction-related issues.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and CoreWeave's and Core Scientific's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries, and changes in local, national, or international laws, regulations, and policies affecting CoreWeave and Core Scientific.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the proposed transaction.
• Certain restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities or strategic transactions or otherwise operate its business.
• Acts of terrorism or outbreak of war, hostilities, civil unrest, attacks against CoreWeave or Core Scientific, and other political or security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events.
• The impacts of pandemics or other public health crises, including the effects of government responses on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites.

Future Outlook

The future outlook centers on the consummation of the proposed acquisition of Core Scientific by CoreWeave and the realization of anticipated benefits, synergies, and value creation from the integration of their businesses. However, these outcomes are subject to significant risks and uncertainties, including regulatory and stockholder approvals, integration challenges, and broader economic and industry conditions.

Industry Context

The proposed acquisition involves companies operating in the artificial intelligence, power, data center, and crypto mining industries. A key strategic element highlighted is the potential conversion of Core Scientific's crypto mining facilities into high-performance computing sites, aligning with the growing demand for AI infrastructure.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders of Core Scientific will be required to make voting or investment decisions regarding the proposed transaction.
• CoreWeave's issuance of additional shares could cause dilution for its existing shareholders.
• Management's time and attention may be diverted to transaction-related issues, potentially impacting employees and operations.
• Potential adverse reactions or changes to business relationships could affect customers and suppliers.

Next Steps

• CoreWeave and Core Scientific will file a registration statement on Form S-4, which will include a proxy statement/prospectus, with the SEC.
• A definitive proxy statement/prospectus will be mailed to stockholders of Core Scientific.
• Core Scientific stockholder approval for the proposed transaction is required.
• Regulatory approvals may be required for the completion of the transaction.

Key Dates

Keywords

CoreWeave, Core Scientific, acquisition, merger, SEC filing, Form 425, Form S-4, proxy statement, prospectus, artificial intelligence, data center, crypto mining, high-performance computing, corporate transaction